Skip to Content

Zamansky LLC Investigates Rockwell Medical Technologies on Behalf of Long-Term Shareholders

May 7, 2013 In The News

Zamansky LLC notifies all investors who purchased common stock of Rockwell Medical Technologies Inc. before February 2010 and who are still holding, that it is investigating possible corporate waste and breaches of fiduciary duties by the officers and directors in the handling of Phase III clinical trials concerning Soluble Ferric Pyrophosphate (SFP), an experimental iron-therapy drug intended to treat iron-deficiency.

Read the full Press Release